IGMS Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - IGM Biosciences Inc

Watchlist Manager

Watchlist

Price: 1.27 USD -2.31%

Market Cap: $76.6m

	IGM Biosciences Inc NASDAQ:IGMS	US
	ACS Actividades de Construccion y Servicios SA OTC:ACSAY	ES
D	Dr Reddy's Laboratories Ltd F:RDDA	IN
	Chunghwa Telecom Co Ltd NYSE:CHT	TW
	Baxter International Inc NYSE:BAX	US
E	Edgewell Personal Care Co F:EGZ	US
	Moskovskiy Kreditnyi Bank PAO MOEX:CBOM	RU

Profitability Summary

IGM Biosciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-9.149%

Operating Margin is Increasing

-15.054% > 7%

Negative Net Margin

-37%

Negative 3Y Average Net Margin

-8.841%

Net Margin is Increasing

-14.373% > -37%

Negative Free Cash Flow Margin

-109%

Negative 3Y Average Free Cash Flow Margin

-7.176%

Free Cash Flow Margin is Increasing

-1.833% > -109%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-255%

ROIC is Increasing

-316% > 26%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.